Efficacy and Safety of Palbociclib Plus Endocrine Therapy in North American Women With Hormone Receptor‐positive/Human Epidermal Growth Factor Receptor 2‐negative Metastatic Breast Cancer
Breast Journal - United Kingdom
doi 10.1111/tbj.13516
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2020
Authors
Publisher
Wiley